Humacyte: Trestle Bio Unveils Research Partnership With Humacyte

(RTTNews) - Trestle Biotherapeutics, Inc. has partnered with Humacyte, Inc. (HUMA) to explore synergies in bioengineering vascularized organs for transplantation. Trestle Bio, a preclinical-stage company, develops bioengineered kidney tissues for end-stage renal disease or ESRD p